Bowel functions, fecal unconjugated primary and secondary bile acids, and colonic transit in patients with irritable bowel syndrome.
about
Bile Acid diarrhea: prevalence, pathogenesis, and therapyKey discoveries in bile acid chemistry and biology and their clinical applications: history of the last eight decadesElobixibat and its potential role in chronic idiopathic constipationEmerging Pharmacologic Therapies for Constipation-predominant Irritable Bowel Syndrome and Chronic Constipation.RNA sequencing shows transcriptomic changes in rectosigmoid mucosa in patients with irritable bowel syndrome-diarrhea: a pilot case-control study.Irritable Bowel Syndrome: Clinical Manifestations, Dietary Influences, and Management.Genetic variation in GPBAR1 predisposes to quantitative changes in colonic transit and bile acid excretion.Advances in understanding of bile acid diarrhea.Validating biomarkers of treatable mechanisms in irritable bowel syndromeMicrobiota transplantation restores normal fecal bile acid composition in recurrent Clostridium difficile infection.Irritable bowel syndrome: an integrated explanatory model for clinical practice.Colonic mucosal gene expression and genotype in irritable bowel syndrome patients with normal or elevated fecal bile acid excretion.Effect of colesevelam on faecal bile acids and bowel functions in diarrhoea-predominant irritable bowel syndromeNew and Emerging Treatment Options for Irritable Bowel Syndrome.Rationale for Investigating Stool Metabolites and Microbiota in Women With Fecal Incontinence.Effects of Rifaximin on Transit, Permeability, Fecal Microbiome, and Organic Acid Excretion in Irritable Bowel Syndrome.Pharmacological agents currently in clinical trials for disorders in neurogastroenterology.Faecal biomarker patterns in patients with symptoms of irritable bowel syndrome.Irritable bowel syndrome-diarrhea: characterization of genotype by exome sequencing, and phenotypes of bile acid synthesis and colonic transit.Current and emergent pharmacologic treatments for irritable bowel syndrome with diarrhea: evidence-based treatment in practice.New pharmacological treatment options for chronic constipation.Bile acid diarrhoea and FGF19: new views on diagnosis, pathogenesis and therapy.The role of bile acids in functional GI disorders.Underlying molecular and cellular mechanisms in childhood irritable bowel syndromeNew and Investigational Agents for Irritable Bowel Syndrome.Performance characteristics of serum C4 and FGF19 measurements to exclude the diagnosis of bile acid diarrhoea in IBS-diarrhoea and functional diarrhoea.Novel investigational drugs for constipation-predominant irritable bowel syndrome: a review.Bile Acid Deficiency in a Subgroup of Patients With Irritable Bowel Syndrome With Constipation Based on Biomarkers in Serum and Fecal Samples.Biomarkers as a diagnostic tool for irritable bowel syndrome: where are we?Chemical and molecular factors in irritable bowel syndrome: current knowledge, challenges, and unanswered questions.Putative mechanisms of kiwifruit on maintenance of normal gastrointestinal function.Colonic Transit and Bile Acid Synthesis or Excretion in Patients With Irritable Bowel Syndrome-Diarrhea Without Bile Acid Malabsorption.Increased colonic bile acid exposure: a relevant factor for symptoms and treatment in IBS.Interplay between bile acid metabolism and microbiota in irritable bowel syndrome.Electrical neuromodulation at acupoint ST36 normalizes impaired colonic motility induced by rectal distension in dogs.Irritable Bowel Syndrome: Pathophysiology and Current Therapeutic Approaches.Characteristics of functional bowel disorder patients: a cross-sectional survey using the Rome III criteria.Effect of increased bile acid synthesis or fecal excretion in irritable bowel syndrome-diarrhea.Home-Based Transcutaneous Neuromodulation Improved Constipation via Modulating Gastrointestinal Hormones and Bile Acids.Authors' response: bile acids are important in the pathophysiology of IBS
P2860
Q28086845-8064F755-C204-4300-B4E8-76671B780301Q28240299-29B30A93-36FC-4331-A3B9-D51EEB92D644Q28244603-ADA1786A-E73A-412C-87A1-CB7101FD115BQ33586854-8D9E616B-E081-43D6-AC18-DEB476133732Q33764582-C87682B7-1378-4175-ABE7-8950911B5703Q33855973-4720C847-6C8D-454E-A9D6-3D4AF7879878Q34131127-27E491D9-A9F5-4BCA-B08D-71FFC96C3C0DQ34412381-301433EC-BEF2-4CA5-91B6-BBA0A5860D81Q34577283-EB089EB0-8638-4778-AFA6-EB152FE459BDQ35055851-ED6B302C-B263-4154-9600-0E1CDED6284FQ35565145-B5BDE673-C182-4842-A8AE-61A9A94D2B4AQ35817782-567D6DCB-4D0D-4152-A044-DF7A83501D6EQ35825711-C9400288-0DA9-47A0-A49A-0107B5EF1EEDQ36180769-526F3E59-31C8-46F6-95E5-28A1D72458F6Q36242190-D9B1D3D1-8C70-4C77-8AA9-11AABFA5FA70Q36970524-0FC288E1-3E9A-456F-A1A4-4E3D064A074EQ37200907-110074F1-2018-44DB-B158-FB3C134D0EA8Q37282505-527E5ABC-8F62-46B8-BC78-1255BBE547CCQ37575689-E87D9DF0-4D48-4A2F-8A80-4E3622062AB1Q37632259-4B51F9BC-05E3-414F-A7F9-44F8D6C42C43Q38198743-13453C5A-50CD-43D7-AA6D-925939B47C67Q38198859-7DCCFBDC-9FB0-4F99-8AAC-C4153294241AQ38217671-731E6C89-F6CA-4160-A557-3D5B3EC3E605Q38515695-6CEB0CB8-ECF6-43A6-8B1F-B41C43FE6020Q38601834-6A4C601B-3E67-4557-BE6C-51BA3271A579Q38687017-C314A593-FFF9-4F25-8561-B1CDB7663E92Q38696256-A236CEEB-978F-4B2F-8C55-D60B5775ED8CQ38699388-30581B80-1A54-4C3F-BE6F-6FEDEB62E158Q38765085-1112DC54-0097-49C5-88D9-6018574362A0Q38800981-E2A55582-9CDA-4FBF-BB74-1FCE1C1B874FQ39154995-CB2EF2D2-FAB7-4F54-9280-26C4594C88F3Q39179801-3994A90B-949F-4BFB-BF83-DBCA60EE808FQ39208620-52F4E348-B344-4000-BA69-F296D194024EQ43913058-D2FD2DEE-3A20-48A7-854E-096AF5DBA418Q47684136-B58BC394-A2D9-4C7E-8DF7-3DF6F772DC69Q48389586-68313D59-719C-4027-A37C-553CD852C3BCQ48390672-30FD4DCB-F132-425C-B946-6C673C53958FQ51318198-4FF02507-D89D-440B-9940-D5EBB514A996Q55292423-0287393A-3718-4C49-903D-7CD9D124B748Q57145186-EDD7C964-2907-4F3D-B2A7-B09A311076C5
P2860
Bowel functions, fecal unconjugated primary and secondary bile acids, and colonic transit in patients with irritable bowel syndrome.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 April 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Bowel functions, fecal unconju ...... with irritable bowel syndrome.
@en
Bowel functions, fecal unconju ...... with irritable bowel syndrome.
@nl
type
label
Bowel functions, fecal unconju ...... with irritable bowel syndrome.
@en
Bowel functions, fecal unconju ...... with irritable bowel syndrome.
@nl
prefLabel
Bowel functions, fecal unconju ...... with irritable bowel syndrome.
@en
Bowel functions, fecal unconju ...... with irritable bowel syndrome.
@nl
P2093
P2860
P921
P1476
Bowel functions, fecal unconju ...... with irritable bowel syndrome.
@en
P2093
Adam Girtman
Alan Lueke
Amy Saenger
Andrea Shin
Deborah Rhoten
Duane Burton
Irene Busciglio
Michael Ryks
Priya Vijayvargiya
P2860
P304
1270-1275.e1
P356
10.1016/J.CGH.2013.04.020
P407
P577
2013-04-30T00:00:00Z